Champions Oncology, Inc.

CSBR · NASDAQ
Analyze with AI
10/31/2025
7/31/2025
4/30/2025
1/31/2025
Operating Activities
Net Income$236-$466-$1,835$4,495
Dep. & Amort.$357$358$394$398
Deferred Tax$0$0$0$0
Stock-Based Comp.$249$208$131$256
Change in WC-$3,005$199$7,727-$4,917
Other Non-Cash$428$301$451$258
Operating Cash Flow-$1,735$600$6,868$490
Investing Activities
PP&E Inv.-$242-$46-$253-$42
Net Acquisitions$0$0$0$0
Inv. Purchases$0$0$0$0
Inv. Sales/Matur.$0$0$0$0
Other Inv. Act.$0$0$0$0
Investing Cash Flow-$242-$46-$253-$42
Financing Activities
Debt Repay.-$39-$38-$38-$38
Stock Issued$207$24$6$38
Stock Repurch.$0$0$0$0
Dividends Paid$0$0$0$0
Other Fin. Act.$0$0$0$0
Financing Cash Flow$168-$14-$32$0
Forex Effect$0$0$0$0
Net Chg. in Cash-$1,809$540$6,583$448
Supplemental Information
Beg. Cash$10,325$9,785$3,202$2,754
End Cash$8,516$10,325$9,785$3,202
Free Cash Flow-$1,977$554$6,615$448